Advair Diskus Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Clinical Endpoint Bioequivalence Study of Fluticasone Propionate & Salmeterol Xinafoate (100 μg/50μg)
Condition: Asthma Interventions: Drug: Fluticasone propionate/salmeterol; Drug: Advair Diskus, 100 Mcg-50 Mcg Inhalation Powder; Drug: Placebo Sponsor: West-Ward Pharmaceutical Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 24, 2018 Category: Research Source Type: clinical trials

Clinical Endpoint Bioequivalence Study of Fluticasone Propionate & Salmeterol Xinafoate (100mg/50mg)
Condition: Asthma Interventions: Drug: Fluticasone/Salmeterol; Drug: Advair Diskus 100/50 Dry Powder Inhaler; Drug: Placebo Sponsors: West-Ward Pharmaceutical; Pharm-Olam International Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 17, 2018 Category: Research Source Type: clinical trials

BE Study of Fluticasone Propionate/Salmeterol Inhalation Powder in Asthma Patients
Condition: Bronchial Asthma Interventions: Drug: Fluticasone propionate/salmeterol 100/50 µg; Other: Placebo; Drug: Advair Diskus 100/50 Dry Powder Inhaler, 60 ACTUAT Sponsor: Cipla Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 9, 2018 Category: Research Source Type: clinical trials

Bioequivalence Study Comparing Fluticasone Propionate/Salmeterol 100/50 µg Inhalation Powder With Advair® Diskus 100/50 µg in Asthma Patients
Condition: Bronchial Asthma Interventions: Drug: Fluticasone propionate/salmeterol 100/50 µg; Other: Placebo; Drug: Advair Diskus 100/50 Dry Powder Inhaler, 60 ACTUAT Sponsor: Cipla Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 9, 2018 Category: Research Source Type: clinical trials